Screener
Xenon Pharmaceuticals XENE Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
FAQ
- What is Xenon Pharmaceuticals's net income?
- Xenon Pharmaceuticals (XENE) reported net income of -$110.74M in Q2 2026.
- How has Xenon Pharmaceuticals's net income changed year-over-year?
- Xenon Pharmaceuticals's net income decreased by 30.7% year-over-year, from -$84.71M to -$110.74M.
- What is the long-term trend for Xenon Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Xenon Pharmaceuticals's net income has grown at a 44.7% compound annual growth rate (CAGR), from -$78.88M to -$345.91M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Xenon Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude